{"id":1200970,"date":"2023-11-08T14:36:00","date_gmt":"2023-11-08T19:36:00","guid":{"rendered":"https:\/\/www.prime-wow.com\/?p=1200970"},"modified":"2023-11-08T14:36:00","modified_gmt":"2023-11-08T19:36:00","slug":"fda-approves-a-new-obesity-drug-poised-to-dethrone-wegovy","status":"publish","type":"post","link":"https:\/\/www.prime-wow.com\/?p=1200970","title":{"rendered":"FDA Approves a New Obesity Drug Poised to Dethrone Wegovy"},"content":{"rendered":"<p><img decoding=\"async\" class=\"type:primaryImage\" src=\"https:\/\/www.prime-wow.com\/wp-content\/uploads\/2023\/11\/1dd6b6387707d6ed528c40fc43633bcf.jpg\" \/><\/p>\n<p>There\u2019s officially a new and fierce competitor for Novo Nordisk\u2019s Wegovy (semaglutide) when it comes to weight loss. On Wednesday, the Food and Drug Administration approved the drug tirzepatide, developed by Eli Lilly, as a treatment for obesity. The weekly injectable drug will be sold under the brand name Zepbound.<\/p>\n<p><a href=\"https:\/\/gizmodo.com\/fda-eli-lilly-zepbound-tirzepatide-weight-loss-drug-1851003843\">Read more&#8230;<\/a><\/p>\n<p>&#013;<br \/>\n&#013;<br \/>\nSource: Gizmodo &#8211; <a href=\"https:\/\/gizmodo.com\/fda-eli-lilly-zepbound-tirzepatide-weight-loss-drug-1851003843\" target=\"_blank\" rel=\"noopener\">FDA Approves a New Obesity Drug Poised to Dethrone Wegovy<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>There\u2019s officially a new and fierce competitor for Novo Nordisk\u2019s Wegovy (semaglutide) when it comes to weight loss. On Wednesday, the Food and Drug Administration approved the drug tirzepatide, developed by Eli Lilly, as a treatment for obesity. The weekly &hellip; <a href=\"https:\/\/www.prime-wow.com\/?p=1200970\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":1200971,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[105,110],"tags":[104],"class_list":["post-1200970","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gizmodo","category-unfiltered-rss","tag-gizmodo"],"_links":{"self":[{"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=\/wp\/v2\/posts\/1200970","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1200970"}],"version-history":[{"count":0,"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=\/wp\/v2\/posts\/1200970\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=\/wp\/v2\/media\/1200971"}],"wp:attachment":[{"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1200970"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1200970"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.prime-wow.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1200970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}